BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21412836)

  • 1. Ventricular enlargement and mild cognitive impairment in early Parkinson's disease.
    Dalaker TO; Zivadinov R; Ramasamy DP; Beyer MK; Alves G; Bronnick KS; Tysnes OB; Aarsland D; Larsen JP
    Mov Disord; 2011 Feb; 26(2):297-301. PubMed ID: 21412836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
    Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
    Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
    Nobili F; Abbruzzese G; Morbelli S; Marchese R; Girtler N; Dessi B; Brugnolo A; Canepa C; Drosos GC; Sambuceti G; Rodriguez G
    Mov Disord; 2009 Feb; 24(3):414-21. PubMed ID: 19235928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease.
    Lee JE; Park HJ; Song SK; Sohn YH; Lee JD; Lee PH
    Neurology; 2010 Nov; 75(22):2009-16. PubMed ID: 21115956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain atrophy and white matter hyperintensities in early Parkinson's disease(a).
    Dalaker TO; Larsen JP; Bergsland N; Beyer MK; Alves G; Dwyer MG; Tysnes OB; Benedict RH; Kelemen A; Bronnick K; Zivadinov R
    Mov Disord; 2009 Nov; 24(15):2233-41. PubMed ID: 19768730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive functions deficit in Parkinson's disease with amnestic mild cognitive impairment.
    Petrova M; Raycheva M; Zhelev Y; Traykov L
    Am J Alzheimers Dis Other Demen; 2010 Aug; 25(5):455-60. PubMed ID: 20484747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease is associated with hippocampal atrophy.
    Camicioli R; Moore MM; Kinney A; Corbridge E; Glassberg K; Kaye JA
    Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.
    Janvin CC; Larsen JP; Aarsland D; Hugdahl K
    Mov Disord; 2006 Sep; 21(9):1343-9. PubMed ID: 16721732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray matter correlations of cognition in incident Parkinson's disease.
    Dalaker TO; Zivadinov R; Larsen JP; Beyer MK; Cox JL; Alves G; Bronnick K; Tysnes OB; Antulov R; Dwyer MG; Aarsland D
    Mov Disord; 2010 Apr; 25(5):629-33. PubMed ID: 20213820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing mild cognitive impairment in Parkinson's disease.
    Dalrymple-Alford JC; Livingston L; MacAskill MR; Graham C; Melzer TR; Porter RJ; Watts R; Anderson TJ
    Mov Disord; 2011 Mar; 26(4):629-36. PubMed ID: 21287603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
    Calabrese M; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Romualdi C; Rinaldi L; Perini P; Gallo P
    Neurology; 2010 Jan; 74(4):321-8. PubMed ID: 20101038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction.
    Saka E; Elibol B
    Parkinsonism Relat Disord; 2009 Nov; 15(9):688-91. PubMed ID: 19446489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI and cognitive impairment in Parkinson's disease.
    Ibarretxe-Bilbao N; Tolosa E; Junque C; Marti MJ
    Mov Disord; 2009; 24 Suppl 2():S748-53. PubMed ID: 19877242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status.
    Song SK; Lee JE; Park HJ; Sohn YH; Lee JD; Lee PH
    Mov Disord; 2011 Feb; 26(2):289-96. PubMed ID: 21370255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.